Methylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinoma. - Kondrashova O; Topp M; Nesic K; Lieschke E; Ho GY; Harrell MI; Zapparoli GV; Hadley A; Holian R; Boehm E; Heong V; Sanij E; et al. (Nature communications, 2018)